Breast Ultrasound Training Workshop

Jun 21st, 2024Jun 23rd, 2024
MTMI International Headquarters 10361 Innovation Drive
Milwaukee, WI
https://www.mtmi.net/course/breast-ultrasound-course?utm_source=aunt_minnie&utm_medium=website&utm_campaign=br_us_2024_catalog
Phone:(262) 717-9797

This course, built for mammography techs, sonographers, and physicians, is designed to deepen technical and clinical understanding of breast ultrasound, with additional hands-on imaging training taught by an experienced sonographer and technologist. An overview of basic principles and techniques in breast ultrasound is presented in preparation for ARRT or ARDMS exams.

Latest in Conference
Road To Rsna
Road to RSNA 2024: Molecular Imaging Preview
November 21, 2024
FAPI-PET/CT superior to FDG-PET/CT in liver cancer patients
November 21, 2024
FAPI-PET/CT improves detection of primary and metastatic breast cancer
November 21, 2024
Theranostics cost-effective in men with mCRPC
November 21, 2024
Related Stories
Covid Brain Visual
ISMRM 2024
ISMRM: Long-COVID researchers learn from voxel-wise analysis in brain MRI
Wright
ISMRM 2024
ISMRM: MRI provides new insights in mild traumatic brain injury
2024 05 06 Sf Low Field Figure 5 Thumbnail
ISMRM 2024
ISMRM: Is low-field MRI coming of age for lung imaging?
Mri Brain Head
ISMRM 2024
ISMRM: MRI shows promise for helping to diagnose PTSD
More in Conference
Road to RSNA 2024: Molecular Imaging Preview
By Will Morton
Theranostics could be cited for speeding in this year’s Road to RSNA. It's only been a few years since a dedicated track in nuclear medicine and molecular imaging was established at the meeting, and the practice already dominates it.
November 21, 2024
Road To Rsna
FAPI-PET/CT superior to FDG-PET/CT in liver cancer patients
By Will Morton
Ga-68 FAPI-PET/CT imaging appears superior to FDG-PET/CT for assessing hepatocellular carcinomas. In a large prospective trial, the approach was more accurate – enough so that it could possibly replace FDG-PET/CT in the future.
November 21, 2024
FAPI-PET/CT improves detection of primary and metastatic breast cancer
By Will Morton
Ga-68 FAPI-PET/CT significantly enhances the detection rate and staging of primary and metastatic breast cancer, demonstrating superior sensitivity and specificity compared with F-18 FDG-PET/CT.
November 21, 2024
Theranostics cost-effective in men with mCRPC
By Will Morton
Using theranostic radionuclides such as Ra-223 or Lu-177 to treat men with metastatic castration-resistant prostate cancer (mCRPC) is more cost-effective in the long term than traditional chemotherapy and radiotherapy, suggests a study in this session.
November 21, 2024
Treatment-related factors enhance PSMA expression
By Will Morton
Certain prostate cancer features on PSMA-PET may be useful in selecting candidates who are more likely to respond to Lu-177 PSMA-617, according to a presentation in this session.
November 21, 2024
F-18 PSMA-DCFPyL and Ga-68 PSMA-11 deemed equivalent
By Will Morton
PET radiopharmaceuticals F-18 PSMA-DCFPyL and a Ga-68 PSMA-11 appear equivalent for determining patient eligibility for prostate cancer treatment with Lu-177 PSMA-617, researchers say.
November 21, 2024
AI segments lesions on Ga-68 DOTATATE PET/CT images
By Will Morton
In this session, researchers will present an automated deep-learning AI model that could help clinicians segment rare neuroendocrine tumors on whole-body 3D gallium-68 (Ga-68) DOTATATE PET/CT images.
November 21, 2024
Are Lu-177 PSMA-617 outcomes applicable in a community setting?
By Will Morton
During this session on theranostics, a study suggests that targeted education is needed to support the delivery of Lu-177 PSMA-617 to patients.
November 21, 2024
FES-PET shows promise for staging invasive lobular carcinoma
By Will Morton
A mid-study analysis presented during this session suggests that F-18 fluoroestradiol (FES) PET/CT may detect unsuspected stage IV invasive lobular carcinoma.
November 21, 2024
Dedicated brain PET system shows promise in Alzheimer’s disease imaging
By Will Morton
A high-resolution dedicated brain PET system could augment visual reading in the early diagnosis of dementia, suggests a study in this session.
November 21, 2024
Can AI chatbots answer questions for patients on Lu-177 PSMA-617 therapy?
By Will Morton
In response to common questions from Lu-177 PSMA-617 patients, Gemini provided easy-to-understand answers and ChatGPT-4 demonstrated high accuracy, yet neither AI chatbot provided completely accurate answers to all questions.
November 21, 2024
AI denoising software valuable for amyloid PET/CT studies
By Will Morton
A study in this session suggests that count-poor and noisy amyloid brain PET/CT studies can be rendered clinically useful through AI denoising software.
November 21, 2024
Page 1 of 656
Next Page